A potent modifier of liver cancer risk on distal mouse chromosome 1: Linkage analysis and characterization of congenic lines

Genetics

Volumn 167, Issue 2, 2004, Pages 859-866

  Bilger, Andrea ^a   Bennett, L Michelle ^a,b   Carabeo, Reynaldo A ^a,c   Chiaverotti, Teresa A ^a,d   Dvorak, Cecily ^a,e   Liss, Kristin M ^a   Schadewald, Susan A ^a   Pitot, Henry C ^a   Drinkwater, Norman R ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e Fairfax Family Practice Centers   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACKCROSSING; CANCER RISK; CANCER SUSCEPTIBILITY; CHEMICAL CARCINOGENESIS; CHROMOSOME 1; CHROMOSOME MAP; CONGENIC STRAIN; CONTROLLED STUDY; FEMALE; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; LINKAGE ANALYSIS; LIVER CANCER; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; MARKER GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CHROMOSOME MAPPING; LIVER NEOPLASMS; MICE; RISK; RODENT DISEASES; SPECIES SPECIFICITY;

ANIMALIA;

EID: 3142670509     PISSN: 00166731     EISSN: None     Source Type: Journal    
DOI: 10.1534/genetics.103.024521     Document Type: Article

References (60)

1. ANDERVONT, H., 1950 Studies on the occurrence of spontaneous hepatomas in mice of strains C3H and CBA. J. Natl. Cancer Inst. 11: 581-592.
2. ASHBY, J, and R. W. TENNANT, 1991 Definitive relation ships among chemical structure, carcinogenicity, and mutagenicity for 301 chemicals tested by the U.S. NTP. Mutat. Res. 257: 229-306.
3. BALMAIN, A., 2002 Cancer as a complex genetic trait: tumor susceptibility in humans and mouse models. Cell 108: 145-152.
4. BECK, J. A., S. LLOYD, M. HAFEZPARAST, M. LENNON-PIERCE, J. T. EPPIG et al., 2000 Genealogies of mouse inbred strains. Nat. Genet. 24: 23-25.
5. BENNETT, L. M., M. L. WINKLER and N. R. DRINKWATER, 1993 A gene that determines the high susceptibility of the C3H/HeJ strain of mouse to liver tumors is located on Chromosome 1. Proc. Am. Assoc. Cancer Res. 34: 144.
6. BENNETT, L. M., P.J. FARNHAM and N. R. DRINKWATER, 1995 Strain-dependent differences in DNA synthesis and gene expression in the regenerating livers of C57BL/6J and C3H/HeJ mice. Mol. Carcinogen. 14: 46-52.
7. BERANEK, D. T., C. C. WEISS and D. H. SWENSON, 1980 A comprehensive quantitative analysis of methylated and ethylated DNA using high pressure liquid chromatography. Carcinogenesis 1: 595-606.
8. BUGNI, J. M., T. M. POOLE and N. R. DRINKWATER, 2001 The little mutation suppresses DEN-induced hepatocarcinogenesis in mice and abrogates genetic and hormonal modulation of susceptibility. Carcinogenesis 22: 1853-1862.
9. CHIAVEROTTI, T. A., and N. R. DRINKWATER, 2003 C57BR/cdJ hepatocarcinogen susceptibility genes act cell-autonomously in C57BR/cdJ,↔C57BL/6J chimeras. Cancer Res. 63: 4914-4919.
10. CHURCHILL, G. A., and R. W. DOERGE, 1994 Empirical threshold values for quantitative trait mapping. Genetics 138: 963-971.
11. CLIMENT, J., J. A. MARTINEZ-CLIMENT, D. BLESA, M. J. GARCIA-BARCHINO, R. SAEZ et al., 2002 Genomic loss of 18p predicts an adverse clinical outcome in patients WITH high-risk breast cancer. Clin. Cancer Res. 8: 3863-3869.
12. COMPLEX TRAIT CONSORTIUM, 2003 The nature and identification of quantitative trait loci: a community's view. Nat. Rev. Genet. 4: 911-916.
13. CONDAMINE, H., R. P. CUSTER and B. MINTZ, 1971 Pure-strain and genetically mosaic liver tumors histochemically identified with the beta-glucuronidase marker in allophenic mice. Proc. Natl. Acad. Sci. USA 68: 2032-2036.
14. AKR intestinal tumor resistance region consists of Pla2g2a and a locus distal to D4Mit64. Oncogene 19: 3182-3192.
15. DIETRICH, W. F. J. MILLER, R. STEEN, M. A. MERCHANT, D. DAIMRON-BOLES et al., 1996 A comprehensive genetic map of the mouse genome. Nature 380: 149-152.
16. DOERGE, R. W., and G. A. CHURCHILL, 1996 Permutation tests for multiple loci affecting a quantitative character. Genetics 142: 285-294.
17. DRAGANI, T. A., G. MANENTI and G. DELLA PORTA, 1987 Genetic susceptibility to murine hepatocarcinogenesis is associated with high growth rate of NDEA-initiated hepatocytes. J. Cancer Res. Clin. Oncol. 113: 223-229.
18. DRAGANI, T. A., G. MANENTI and G. DELLA PORTA, 1991 Quantitative analysis of genetic susceptibility to liver and lung carcinogenesis in mice. Cancer Res. 51: 6299-6303.
19. DRINKWATER, N. R., 1989 Genetic control of hepatocarcinogenesis in inbred mice, pp. 3-17 in Genes and Signal Transduction in Multistage Carcinogenesis, edited by N. H. COLBURN. Dekker, New York.
20. DRINKWATER, N. R., and J. J. GINSLER, 1986 Genetic control of hepatocarcinogenesis in C57BL/6J and C3H/HeJ inbred mice. Carcinogenesis 7: 1701-1707.
21. FLAKS, A., 1968 The susceptibility of various strains of neonatal mice to the carcinogenic effects of 9,10-dimethyl-1,2-benzanthracene. Eur. J. Cancer 4: 579-585.
22. FRITH, C. H., and L. WILEY, 1982 Spontaneous hepatocellular neoplasms and hepatic hemangiosarcomas in several strains of mice. Lab. Anim. Sci. 32: 157-162.
23. GARIBOLDI M., G. MANENTI, F. CANZIAN, F. S. FALVELLA, M. A. PIEROTTI et al., 1993 Chromosorne mapping of murine susceptibility loci to liver carcinogenesis. Cancer Res. 53: 209-211.
24. GRASSO, P., and J. HARDY, 1975 Strain difference in natural incidence and response to carcinogens, pp. 111-131 in Mouse Hepatic Neoplasia, edited by W. H. BUTLER and P. M. NEWBERNE. Elsevier, Amsterdam.
25. GUAN, X. Y., Y. FANG, J. S. SHAM, D. L. KWONG, Y. ZHANG et al., 2000 Recurrent chromosome alterations in hepatocellular carcinoma detected by comparative genomic hybridization. Genes Chromosomes Cancer 29: 110-116.
26. HANIGAN, M. H., C. J. KEMP, J. J. GINSLER and N. R. DRINKWATER, 1988 Rapid growth of preneoplastic lesions in hepatocarcinogen-sensitive C3H/HeJ male mice relative to C57BL/6J male mice. Carcinogenesis 9: 885-890.
27. HANIGAN, M. H., M. L. WINKLER and N. R. DRINKWATER, 1990 Partial hepatectomy is a promoter of hepatocarcinogenesis in C57BL/ 6J male mice but not in C3H/HeJ male mice. Carcinogenesis 11: 589-594.
28. HISLOP, R. G., N. PRATT, S. C. STOCKS, C. M. STEEL, M. SALES et al., 2002 Karyotypic aberrations of chromosomes 16 and 17 are related to survival in patients with breast cancer. Br. J. Surg. 89: 1581-1586.
29. HOOVER, K. L., C. L., HYDE, M. L. WENK and L. A. POIRIER, 1986 Ethionine carcinogenesis in CD-1, BALB/c and C3H mice. Carcinogenesis 7: 1143-1148.
30. KAKIZOE, S., S. GOLDFARB and T. D. PUGH, 1989 Focal impairment of growth in hepatocellular neoplasms of C57BL/6 mice: a possible explanation for the strain's resistance to hepatocarcinogenesis. Cancer Res. 49: 3985-3989.
31. KEMP, C. J., and N. R. DRINKWATER, 1989 Genetic variation in liver tumor susceptibility, plasma testosterone levels, and androgen receptor binding in six inbred strains of mice. Cancer Res. 49: 5044-5047.
32. KEMP, C. J., C. N. LEARY and N. R. DRINKWATER, 1989 Promotion of murine hepatocarcinogenesis by testosterone is androgen receptor-dependent but not cell autonomous. Proc. Natl. Acad. Sci. USA 86: 7505-7509.
33. KRUGLYAK, L., and E. S. LANDER, 1995 A nonparametric approach for mapping quantitative trait loci. Genetics 139: 1421-1428.
34. LEE, G. H., and N. R. DRINKWATER, 1995a Hepatocarcinogenesis in BXH recombinant inbred strains of mice: analysis of diverse phenotypic effects of the hepatocarcinogen sensitivity loci. Mol. Carcinogen. 14: 190-197.
35. LEE, G. H., and N. R. DRINKWATER, 1995b The Hcr (Hepatocarcinogen Resistance) loci of DBA/2J mice partially suppress phenotypic expression of the Hcs (Hepatocarcinogen Sensitivity) loci of C3H/ HeJ mice. Carcinogenesis 16: 1993-1996.
36. LEE, G. H., K. NOMURA, H. KANDA, M. KUSAKABE, A. YOSHIKI et al., 1991 Strain specific sensitivity to diethylnitrosamine-induced carcinogenesis is maintained in hepatocytes of C3H/HeN in equilibrium with C57BL/6N chimeric mice. Cancer Res. 51: 3257-3260.
37. LEE, G. H. L. M. BENNETT, R. A. CARABEO and N. R. DRINKWATER, 1995 Identification of hepatocarcinogen-resistance genes in DBA/2 mice. Genetics 139: 387-395.
38. LEEMAN, E. L., 1998 Nonparametricss: Statistical Methods Based on Ranks. Prentice-Hall, Upper Saddle River, NJ.
39. LIN, Y. W., J. C. SHEU, G. T. HUANG, H. S. LEE, C. H. CHEN et al., 1999 Chromosomal abnormality in hepatocellular carcinoma by comparative genomic hybridisation in Taiwan. Eur. J. Cancer 35: 652-658.
40. LYSTIG, T. C, 2003 Adjusted P values for genome-wide scans. Genetics 164: 1683-1687.
41. MALKINSON, A. M., and D. S. BEER, 1983 Major effect on susceptibility to urethane-induced pulmonary adenoma by a single gene in BALB/cBy mice. J. Natl. Cancer Inst. 70: 931-936.
42. MANENTI, G., O. BINELLI, M. GARIBOLDI, F. CANZIAN, L. DE GREGORIO et al., 1994 Multiple loci affect genetic predisposition to hepatocarcinogenesis in mice. Genomics 23: 118-124.
43. MARCHIO, A., P. PINEAU, M. MEDDEB, B. TERRIS, P. TIOLLAIS et al., 2000 Distinct chromosomal abnormality pattern in primary liver cancer of non-B, non-C patients. Oncogene 19: 3733-3738.
44. MCALEER, M. A., T. J. AITMAN, R. J. CORNALL, S. GHOSH, J. R. HALL et al., 1992 Linkage analysis of 84 microsatellite markers in intra-and interspecific backcrosses. Mamm. Genome 3: 457-460.
45. NAGASAKI, H., H. KAWABATA, Y. MIYATA, K. INOUE, K. HIRAO et al., 1975 Effect of various factors on induction of liver tumors in animals by the alpha-isomer of benzene hexachloride. Gann 66: 185-191.
46. POOLE, T. M., and N. R. DRINKWATER, 1996 Two genes abrogate the inhibition of murine hepatocarcinogenesis by ovarian hormones. Proc. Natl. Acad. Sci. USA 93: 5848-5853.
47. PUGH, T. D., and S. GOLOFARB, 1992 Growth kinetics of microscopic hepatocellular neoplasms in carcinogen-resistant and carcinogen-responsive strains of mice. Cancer Res. 52: 280-284.
48. SHAM, J. S., T. C. TANG, Y. FANG, L. SUN, L. X. QIN et al., 2002 Recurrent chromosome alterations in primary ovarian carcinoma in Chinese women. Cancer Genet. Cytogenet. 133: 39-44.
49. SMITH, G. S., and R. L. WALFORD, 1978 Influence of the H-2 and H-1 histocompatibility systems upon life span and spontaneous cancer incidences in congenic mice. Birth Defects 14: 281-312.
50. 1 hybrids. J. Natl. Cancer Inst. 50: 1195-1213.
51. STORER, J. B., 1966 Longevity and gross pathology, at death in 22 inbred mouse strains. J. Gerontol. 21: 404-409.
52. TORNILLO, L., V. CARAFA, J. RICHTER, G. SAUTER, H. MOCH et al., 2000 Marked genetic similarities between hepatitis B virus-positive and hepatitis C virus-positive hepatocellular carcinomas. J. Pathol. 192: 307-312.
53. TURUSOV, V. S., N. S. LANKO, V. A. KRUTOVSKIKH and Y. D. PARFENOV, 1982 Strain differences in susceptibility of female mice to 1,2-dimethylhydrazine. Carcinogenesis 3: 603-608.
54. VESSELINOVITCH, S. D., 1990 Perinatal mouse liver carcinogenesis as a sensitive carcinogenesis model and the role of the sex hormonal environment in tumor development. Prog. Clin. Biol. Res. 331: 53-68.
55. VESSELINOVITCH, S. D., and N. MIHAILOVICH, 1967 The effect of gonadectomy on the development of hepatomas induced by, urethan. Cancer Res. 27: 1788-1791.
56. 1 mouse. Proc. Natl. Acad. Sci. USA 83: 5825-5829.
57. WONG, N., P. LAI S. W. LEE, S. FAN E. PANG et al., 1999 Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization analysis: relationship to disease stage, tumor size, and cirrhosis. Am J Pathol. 154: 37-43.
58. WONG, N., P. LAI, E. PANG, L. F. FUNG, Z. SHENG et al., 2000 Genomic aberrations in human hepatocellular carcinomas of differing etiologies. Clin. Cancer Res. 6: 4000-4009.
59. WONG N., W. C. LAM, P. B. LAI, E. PANG, W. Y LAU et al., 2001 Hypomethylation of chromosome 1 heterochromatin DNA correlates with q-arm copy gain in human hepatocellular carcinoma. Am. J. Pathol. 159: 465-471.
60. ZONDERVAN, P. E., J. WINK, J. C. ALERS, J. N. IJZERMANS, S. W. SCHALM et al., 2000 Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias. J. Pathol. 192: 207-215.